Edgar Filing: LUCENT TECHNOLOGIES INC

PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(3)
(TO PROSPECTUS DATED JANUARY 8, 2002) REGISTRATION NO. 333-72282

[LUCENT LOGO]
LUCENT TECHNOLOGIES INC.

1,885,000 SHARES OF 8.00% REDEEMABLE
CONVERTIBLE PREFERRED STOCK

$1,885,000,000 PRINCIPAL AGGREGATE AMOUNT OF 8.00% CONVERTIBLE SUBORDINATED
DEBENTURES ISSUABLE IN EXCHANGE FOR THE PREFERRED STOCK

252,005,273 SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THE CONVERSION
PRIVILEGE ATTACHED TO THE PREFERRED STOCK OR CONVERTIBLE SUBORDINATED DEBENTURES

46,328,725 SHARES OF COMMON STOCK ISSUABLE IN CONNECTION WITH THE PAYMENT OF
DIVIDENDS ON THE PREFERRED STOCK

This prospectus supplement relates to resales of preferred stock and to
sales of convertible subordinated debentures that may be issued in exchange for
preferred stock and to common stock that may be issued upon conversion of
preferred stock or convertible subordinated debentures, by the securityholders
named under the caption "Selling Securityholders" in this prospectus supplement
and the accompanying prospectus, all as described under the caption "Plan of
Distribution" in the accompanying prospectus. This prospectus supplement should
be read in conjunction with the accompanying prospectus dated January 8, 2002,
which is to be delivered with this prospectus supplement.

The table appearing under "Selling Securityholders" in the accompanying
prospectus is hereby amended by the addition of, or the listing of additional
securities for, the following selling securityholders:

PRINCIPAL AMOUNT SHARES OF
SHARES OF OF CONVERTIBLE SHARES OF COMMON STOCK
PREFERRED SUBORDINATED COMMON OWNED PRIOR TO
SELLING SECURITYHOLDER(1) STOCK(2) DEBENTURES(2)(3) STOCK(4) THIS OFFERING
------------------------- --------- ---------------- ---------- --------------

Allete, Inc. .............................................. 500 500,000 66,845 nil
Allstate Insurance Company................................. 1,200 1,200,000 160,428 287,245
Allstate Life Insurance Company............................ 550 550,000 73,530 13,155
Banc of America Securities LLC(5).......................... 2,850 2,850,000 381,016 nil
BNP Paribas Equity Strategies, SNC(5)...................... 3,451 3,451,000 461,364 nil
Charitable Convertible Securities Fund..................... 1,100 1,100,000 147,059 nil
Chilton New Era Partners, L.P. ............................ 6,699 6,699,000 895,588 nil
Chilton New Era International, L.P. ....................... 11,853 11,853,000 1,584,626 nil
Chilton Investment Partners, L.P. ......................... 5,809 5,809,000 776,605 nil
Chilton QP Investment Partners, L.P. ...................... 4,991 4,991,000 667,246 nil
Chilton International, L.P. ............................... 19,473 19,473,000 2,603,342 nil
COOPERNEFF Convertible Strategies Fund, L.P.(5) ........... 1,086 1,086,000 145,188 nil
Concordia Partners LP...................................... 15,500 15,500,000 2,072,192 nil
EB Convertible Securities Fund............................. 1,100 1,100,000 147,059 nil
Fidelity Advisor Series I: Fidelity Advisor Equity Value
Fund(5)(6)............................................... 32 32,000 4,279 nil
Fidelity Financial Trust: Fidelity Convertible Securities
Trust(6)................................................. 2,000 2,000,000 267,380 nil
Fidelity Financial Trust: Fidelity Equity-Income II
Fund(5)(6)............................................... 4,623 4,623,000 618,048 nil
Field Foundation of Illinois............................... 50 50,000 6,685 nil
Franklin World Telecom Fund-Canada......................... 100 100,000 13,369 nil
GDO Equity Arbitrage Master Fund........................... 5,000 5,000,000 668,449 nil
GenCorp Foundation......................................... 35 35,000 4,680 nil
Goldman Sachs and Company.................................. 379 379,000 50,669 nil
Health Foundation of Greater Cincinnati.................... 180 180,000 24,065 nil
Jeffries & Company, Inc.................................... 6,000 6,000,000 802,139 nil
JMG Triton Offshore Fund, Ltd. (5)......................... 2,500 2,500,000 334,225 nil
JP Morgan Securities Inc.(5) .............................. 39,820 39,820,000 5,323,528 1,020,095
Key Trust Convertible Securities Fund...................... 180 180,000 24,065 nil
Merrill Lynch Pierce Fenner & Smith Inc. .................. 284 284,000 37,968 nil
Parker Key/Convertible..................................... 285 285,000 38,102 nil
Potlatch................................................... 760 760,000 101,605 nil
Prudential Property and Casualty Insurance Company......... 260 260,000 34,760 nil

(continued next page)

(continued from previous page)

Prudential Insurance Company of America.................... 3,835 3,835,000 512,701 nil
Prudential Property and Casualty Insurance Company of New
Jersey................................................... 195 195,000 26,070 nil
Sage Capital............................................... 2,000 2,000,000 267,380 nil
SG Hambros Trust Company (Jersey) as Trustee of the Lyxor
Master Fund.............................................. 475 475,000 63,503 nil
Sturgeon Limited (5)....................................... 463 463,000 61,899 nil
UBS AG, London Branch(5)................................... 64,923 64,923,000 8,679,543 nil
Variable Insurance Products Fund: Value Portfolio(5)(6).... 5 5,000 669 nil
Victory Convertible Fund................................... 790 790,000 105,615 nil
Other selling securityholders(1)........................... 9,386 9,386,000 1,254,813 Unknown

---------------

(1) Information about other selling securityholders may be provided in
prospectus supplements or post-effective amendments.

(2) In each case, none of these securities were held prior to this offering.

(3) Based on the principal amount of convertible subordinated debentures
originally issuable in exchange for the preferred stock, calculated by
reference to the initial liquidation preference of the preferred stock of
$1,000.00 per share. The principal amount is subject to increase as a result
of increases in the liquidation preference of the preferred stock to reflect
the accretion of unpaid dividends. See "Description of Preferred
Stock -- Exchange Right" in the accompanying prospectus.

(4) Based on the shares of common stock originally issuable upon exercise of the
conversion privilege attached to the preferred stock or the convertible
subordinated debentures with fractions rounded up to the nearest whole
share. The number of shares of common stock so issuable is subject to
increase as a result of antidilution adjustments and, in the case of
conversion of the preferred stock, increases in the liquidation preference
of the preferred stock to reflect the accretion of unpaid dividends. No
fractional shares of common stock will be issued upon conversion of the
preferred stock. Instead of issuing fractional shares, we will deliver scrip
that will entitle the holder to receive a full share upon surrender of such
scrip aggregating a full share. See "Description of Preferred
Stock -- Conversion Rights" and Description of the Convertible Subordinated
Debentures -- Conversion," in the accompanying prospectus.

(5) The number of securities listed in this prospectus supplement against the
name of this selling securityholder is in addition to the number of
securities listed against the name of this selling securityholder in the
accompanying prospectus.

(6) The selling securityholder is either an investment company or a portfolio of
an investment company registered under Section 8 of the Investment Company
Act of 1940, as amended, or a private investment account advised by Fidelity
Management & Research Company, or FMR Co. FMR Co. is a Massachusetts
corporation and an investment advisor registered under Section 203 of the
Investment Advisers Act of 1940, as amended, and provides investment
advisory services to the selling securityholder, and to other registered
investment companies and to certain other funds which are generally offered
to a limited group of investors. FMR Co. is a wholly owned subsidiary of FMR
Corp., a Massachusetts corporation.

---------------------

Unless otherwise disclosed in the footnotes to the table above, no selling
securityholder has, or within the past three years has had, any position, office
or other material relationship with us or any or our predecessors or affiliates.

Our common stock trades on The New York Stock Exchange under the symbol
"LU". On March 28, 2002, the closing sale price of our common stock was $4.73
per share.

INVESTING IN OUR PREFERRED STOCK, CONVERTIBLE SUBORDINATED DEBENTURES OR
OUR COMMON STOCK INVOLVES RISKS. "RISK FACTORS" BEGINS ON PAGE 9 OF THE
ACCOMPANYING PROSPECTUS.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE
ADEQUACY OR ACCURACY OF THIS PROSPECTUS SUPPLEMENT OR THE PROSPECTUS WHICH
ACCOMPANIES THIS PROSPECTUS SUPPLEMENT. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.

The date of this prospectus supplement is March 29, 2002